<Record>
<Term>Dopamine Agonists</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Dopamine Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Molecular Mechanisms of Pharmacological Action/Neurotransmitter Agents/Dopamine Agents/Dopamine Agonists</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Physiological Effects of Drugs/Neurotransmitter Agents/Dopamine Agents/Dopamine Agonists</ClassificationPath>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Dopamine Agonists</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Dopamine Agents</BroaderTerm>
<BroaderTerm>Molecular Mechanisms of Pharmacological Action</BroaderTerm>
<BroaderTerm>Physiological Effects of Drugs</BroaderTerm>
<BroaderTerm>Neurotransmitter Agents</BroaderTerm>
<Synonym>Dopamine Receptor Agonist</Synonym>
<Synonym>Dopaminergic Agonists</Synonym>
<Synonym>Dopamine Agonists</Synonym>
<Synonym>Dopamine Agonist</Synonym>
<Synonym>Dopaminergic Agonist</Synonym>
<Synonym>Dopamine Receptor Agonists</Synonym>
<Description>Drugs that bind to and activate dopamine receptors.</Description>
<Source>MeSH</Source>
</Record>
